NSCLC Isotoxic Hypofractionated Chemoradiotherapy

NCT03606239 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Carcinoma, Non-Small-Cell Lung

Interventions

RADIATION: isotoxic hypofractionated group

Sponsor

The Second Hospital of Hebei Medical University